A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China

BACKGROUND AND OBJECTIVE: Currently, the detection rates of methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCoNS) in the blood cultures of neonates with sepsis exceed the national average drug resistance level, and vancomycin and linezolid are the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Linjun, Ding, Leyun, Tang, Lian, Yang, Zuming, Wu, Dan, Wang, Wenjuan, Mao, Juehui, Shi, Lu, Liu, Chun, Duan, Lufen, Xu, Jinhui, Zhou, Qin, Sun, Jiantong, Ding, Xinyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357666/
https://www.ncbi.nlm.nih.gov/pubmed/37468855
http://dx.doi.org/10.1186/s12913-023-09628-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357666/
https://www.ncbi.nlm.nih.gov/pubmed/37468855
http://dx.doi.org/10.1186/s12913-023-09628-9

Ejemplares similares